Smartphone App Fails FTC Test On Measuring Blood Pressure
A settlement with "Instant Blood Pressure App" marketer Aura Labs marks FTC's latest enforcement against firms marketing OTC devices that make unsubstantiated health claims.
You may also be interested in...
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.